E-LIB Suche - Ergebnisse für: Asher, Samir

1

Impact of timing of stem cell return following high dose me..:

Nesr, George ; Shah, Raakhee ; Kyriakou, Charalampia...
Leukemia & Lymphoma. 64 (2023) 8 - p. 1465-1471 , 2023

Link: https://doi.org/10.1080/..

2

PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLIN..:

Sridhar, Amrutha ; Chavda, Selina ; Hsu, Hannah...
HemaSphere. 7 (2023) S3 - p. e8120972 , 2023

Link: https://doi.org/10.1097/..

3

P-479 Disparities in clinical trial enrolment and survival ..:

Sridhar, Amrutha ; Chavda, Selina ; Hsu, Hannah...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S303-S304 , 2023

Link: https://doi.org/10.1016/..

4

P-322 Real world outcomes of belantamab mafodotin from the ..:

Watson, Edmund ; Djebbari, Faouzi ; Panitsas, Fotios...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S215-S216 , 2023

Link: https://doi.org/10.1016/..

5

Under-representation of ethnic minorities in early phase cl..:

Asher, Samir ; Kazantzi, Aikaterini ; Dekaj, Fatjon...
Haematologica. 107 (2022) 12 - p. 2961-2965 , 2022

Link: https://doi.org/10.3324/..

6

Risk and response adapted therapy following autologous stem..:

Royle, Kara-Louise ; Coulson, Amy Beth ; Ramasamy, Karthik...
BMJ Open. 12 (2022) 11 - p. e063037 , 2022

Link: https://doi.org/10.1136/..

7

P-206: Antibodies to omicron variants are maintained in new..:

Asher, Samir ; Faustini, Sian ; paterson, Andrea...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S148-S149 , 2022

Link: https://doi.org/10.1016/..

8

AL amyloidosis:

Asher, Samir ; Kazmi, Majid
Medicine. 49 (2021) 5 - p. 314-316 , 2021

Link: https://doi.org/10.1016/..

9

Myeloma and MGUS:

Asher, Samir ; Streetly, Matthew J.
Medicine. 49 (2021) 5 - p. 307-313 , 2021

Link: https://doi.org/10.1016/..

10

Current and future therapies for myelofibrosis:

Asher, Samir ; McLornan, Donal P. ; Harrison, Claire N.
Blood Reviews. 42 (2020) - p. 100715 , 2020

Link: https://doi.org/10.1016/..

11

Impact of timing of stem cell return following high dose me..:

Nesr, George ; Shah, Raakhee ; Kyriakou, Charalampia...
https://discovery.ucl.ac.uk/id/eprint/10171411/1/Impact%20of%20timing%20of%20stem%20cell%20return%20following%20high%20dose%20melphalan%20in%20multiple%20myeloma%20patients%20with%20renal%20impairment%20a%20single%20center%20experience.pdf. , 2023

Link: https://discovery.ucl.ac..

12

PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLIN..:

Sridhar, Amrutha ; Chavda, Selina ; Hsu, Hannah...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429521/. , 2023

Link: http://www.ncbi.nlm.nih...

13

Risk and response adapted therapy following autologous stem..:

Royle, Kara-Louise ; Coulson, Amy Beth ; Ramasamy, Karthik...
https://www.repository.cam.ac.uk/handle/1810/344476. , 2022

Link: https://www.repository.c..

14

Under-representation of ethnic minorities in early phase cl..:

Asher, Samir ; Kazantzi, Aikaterini ; Dekaj, Fatjon...
https://discovery.ucl.ac.uk/id/eprint/10154775/1/10789-Article%20Text-78965-2-10-20221125.pdf. , 2022

Link: https://discovery.ucl.ac..

15

Risk and response adapted therapy following autologous stem..:

Royle, Kara-Louise ; Coulson, Amy Beth ; Ramasamy, Karthik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677008/. , 2022

Link: http://www.ncbi.nlm.nih...